UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2019 » Volume 27, issue 1 (98) » Treatment of patients with dyscirculatory encephalopathy on a background of metabolic syndrome

Treatment of patients with dyscirculatory encephalopathy on a background of metabolic syndrome

Authors

Type of Article

  • Scientific Article

In the Section

  • MECHANISMS OF FORMATION AND MODERN PRINCIPLES OF TREATMENT OF NEUROLOGICAL DISORDERS

Key words

Index UDK:
  • 616.831-008.9-08

Abstract

The article is devoted to investigations of dynamics of neurological and cognitive status changes in patients with dyscirculatory encephalopathy on a background of metabolic syndrome. It was demonstrated, that therapy with Mеmоkоr enables to fasten signifi cantly recovery of impaired neurological functions, to improve parameters of daily life activities, to ameliorate cognitive functioning. Usage of Mеmоkоr is safe and might be recommended for rehabilitation of patients with dyscirculatory encephalopathy on a background of metabolic syndrome for their more complete and rapid functional recovery.

Pages

  • 14-19

Year / Issue

Download PDF

References

  1. The state of neurological service in Ukraine in 2016. 2017. 27 с.
  2. Damulin I. V. V., Zakharov V. V. Dyscirculatory encephalopathy: methodical recommendations. М., 2000. 20 с.
  3. Treschinskaya M. A. Theoretical and practical aspects of the use of L-arginine for the prevention of cerebrovascular pathology // Ukr. med. chasopis. 2011. С. 1-12.
  4. Storozhakov G. I., Fedotova G. S., Cherviakova Y. B. Endothelial dysfunction in arterial hypertension // Medicine. 2005. № 4. С. 58-64.
  5. Konopleva L. F. Endothelial dysfunction in the pathogenesis of cardiovascular diseases and methods of its correction // Therapy. 2011. № 3 (56). С. 26-30.
  6. Clinical features of the course of acute cerebrovascular disorders in patients with metabolic syndrome / T.I. Nasonova, V.L. Veselsky, V.Y. Krylova, G.V. Goreva // International Neurological Journal. 2008. № 1. С. 51-53.
  7. Strongina M. L. Clinical and pathogenetic features of neurological disorders in metabolic syndrome in patients with diabetes mellitus type 2 : author's thesis for the degree of Candidate of Medical Sciences : 14.00.13 - Nervous Diseases. Nizhny Novgorod, 2005. 24 с.
  8. Virstyuk OA, Gerasymchuk RD Features of the course of acute ischemic stroke in the presence of metabolic syndrome // Ukrainian Neurological Journal. 2009. № 3 (12). С. 011-015.
  9. Bachynska N., Kopchak O. The role of modifiable risk factors in the development of moderate cognitive impairment in patients with discirculatory encephalopathy and metabolic syndrome // Ibid. 2014. № 1. С. 53-60. URL : http:// nbuv.gov.ua/UJRN/UNJ_2014_1_10.
  10. Efimova I. Yu, Kalashnikova TP, Lishmanov Y. B. Effect of antihypertensive therapy on cerebral hemodynamics in patients with metabolic syndrome // Clinical Medicine. 2012. Т. 90, № 8. С. 36-40.
  11. Sergeev V. Metabolic syndrome: causes, treatment and prevention // Physician. 2009. № 2. С. 36-41.
  12. Chazova I.E., Mychka V.B. Metabolic syndrome. М. Media Medica, 2004. С. 47-49.
  13. The role of free and esterified fatty acids in the formation of metabolic syndrome / Novogorodtseva K. P., Karaman Yu. K. K., Antoniuk M. V., Zhukova N. V. // Clinical Medicine. 2009. № 5. С. 33-37.
  14. Esterified and non-esterified individual fatty acids of serum lipids in patients with hyperlipidemia while taking statins / Titov V. N., Kukharchuk V. V., Fedorov S. V.. В. [et al.] // Clinical Laboratory Diagnostics. 2006. № 1. С. 1-8.
  15. Frequence of the WHO metabolic syndrome in Euro pean cohorts and an alternative definition of an insulin resistance syndrome / Balkau B., Charles M. A., Drivsholm T. [et al.] // Diabetes Metab. 2002. 28(5). P. 364—376. URI : http://discovery.ucl.ac.uk/id/eprint/75372.
  16. Drapkina OP Features of the course and treatment of arterial hypertension in elderly patients with metabolic syndrome // Pharmateka. 2010. № 8. С. 39-44.
  17. Smith T. Growth hormone — induced insulin resistance: rile of the insulin receptor, IRS1, GLUT1 // Am  J  1997, 272. P. 1071—1079.
  18. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) // JAMA. 2001, 285. P. 2447—2486.
  19. Mankovsky B. N. Stroke and diabetes mellitus: an endocrinologist's view // Zdorov'ya Ukrainy. 2011. № 1 (15). С. 38.
  20. Insulin Resistance and Hyper-secretion in Obesity / Ferrannini  , Natali A., Bell P. [et  al.]  // J.  Clin. Invest. 1997. Vol. 100. P. 1166—1173.
  21. Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure / K. Karasona, L. Sjôstrôm, I.  Wallentin [et  ]  // Eur. Heart  J. 2003. Vol.  24. P. 1500—1505.
  22. Insulin resistance and hyperinsulinemia: no independent relation to left ventricular mass in humans / A. Q. Galvan, F. Galetta, A. Natali [et al.] // Circulation. 2000. Vol. 102. P. 2233—2238.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»